Sales · Startup · Founder News
EN|中文 New? Start Here

AuthorJason

The Founder’s Daily

AuthorJason | Sales, Startup and Founder News

Breaking
BreakingLoading latest headlines…
Loading lead story…

Latest News

All posts →
Loading latest posts…

Departments

Browse all →
Loading departments…

The Founder’s Directory

A curated index of the sales tools, experts, startups and partners we actually use and recommend.

Future of Selling System

Multiply your speed of result WITH US.

Stop pitching harder. Start pitching sharper. Get the system founders use to close faster.

New? Start Here Or get the Future of Selling System →
“Jeffrey Teo: 63 customers in 100 days”  ·  “Leon: a $2M partnership”
See all success stories →
Neurosterix Raises $105M Series B to Build the Next Generation of Neuropsychiatric Therapies
8

Neurosterix Raises $105M Series B to Build the Next Generation of Neuropsychiatric Therapies

Geneva and Boston-based Neurosterix has closed a $105 million Series B to advance its pipeline of allosteric modulator drugs targeting complex neuropsychiatric disorders — a field where patients have waited decades for meaningful new medicines.

Isomorphic Labs Raises $5B Before Naming a Drug Candidate: What the Round Does and Doesn't Tell Us

Isomorphic Labs closed a $5 billion Series C on Nov 17, 2026. Here is what is confirmed, what is not, and what AI-bio founders should take from it.

Seawolf Therapeutics Surfaces With $100M and a $1.2B Sanofi Deal to Rewrite DNA Medicine
6

Seawolf Therapeutics Surfaces With $100M and a $1.2B Sanofi Deal to Rewrite DNA Medicine

San Diego biotech Seawolf Therapeutics emerged from stealth on November 16, 2026 with $100M in Series A financing and a multi-target deal with Sanofi worth up to $1.2B, built on its TRIDENT DNA delivery platform.

Galvanize Therapeutics Closes $130M Series D to Expand Pulsed Electric Field Cancer Surgery
6

Galvanize Therapeutics Closes $130M Series D to Expand Pulsed Electric Field Cancer Surgery

Galvanize Therapeutics has closed an oversubscribed $130 million Series D to scale its pulsed electric field surgical ablation platform for soft-tissue cancers, bringing a category of energy-based therapy toward broader clinical use.

How Billionaire Richard Branson Made Early Adopters Feel Like Pioneers
14

How Billionaire Richard Branson Made Early Adopters Feel Like Pioneers

How Richard Branson converted skeptics into early adopters by making them feel like pioneers. Founder early adopter scripts plus P.I.T.C.H. Formula. From $19/mo.

How Billionaire Jeff Bezos Built Amazon’s Trust Before It Had Proof
16

How Billionaire Jeff Bezos Built Amazon’s Trust Before It Had Proof

How Jeff Bezos built Amazon's credibility before having any track record. Founder credibility scripts plus P.I.T.C.H. Formula. From $19/mo.

How Billionaire Mark Cuban Disrupted Pharmaceutical Pricing
17

How Billionaire Mark Cuban Disrupted Pharmaceutical Pricing

How Mark Cuban disrupted pharma pricing and what every biotech founder can learn. Founder biotech pricing scripts plus P.I.T.C.H. Formula. From $19/mo.

How Billionaire Bill Gates Gets Hospitals and Health Systems to Adopt New Technology
18

How Billionaire Bill Gates Gets Hospitals and Health Systems to Adopt New Technology

How Bill Gates sells new tech to hospitals and health systems against institutional resistance. Founder health system scripts plus P.I.T.C.H. Formula. From $19/mo.